Griesbach & Associates have been chosen to help with the development of a set of needle exchange guidelines for Scotland.   This project is an action arising from Phase II of Scotland’s Hepatitis C Action Plan (Action 14, p. 18).  Dawn Griesbach will be working closely with the members of the Guidelines Development Group, which is chaired by Professor Avril Taylor (University of the West of Scotland).